Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy [Corrigendum]

Yang H, Cong T, Luo Y, Yang C, Ren J, Li X. J Hepatocell Carcinoma. 2024;11:175–189.

The authors have advised that they neglected to include a funding statement on page 187 of the published paper. The funding statement should read as follows.

FundingThis work was supported by the National Natural Science Foundation of China (82330061).

The authors apologize for any inconvenience caused to the readers.